期刊文献+

射干活性成分对花生四烯酸代谢酶LTA4H的分子模拟研究 被引量:8

Molecular Simulation Studies of Active Ingredients in Belamcanda chinensis on One of the Arachidonic Acid Metabolizing Enzymes LTA4H
下载PDF
导出
摘要 目的利用分子对接技术研究射干活性成分对花生四烯酸代谢酶活性的影响。方法采用AUTODOCK软件,以白三烯A4水解酶(LTA4H)为配体对射干中所含8种活性成分进行筛选研究。结果射干中8种活性成分与LTA4H分子对接结合自由能介于-7.85^-10.29kcal·mol^(-1),主要作用在以Glu296、Asp375、Arg563、Ser379等氨基酸残基组成的活性位点。结论射干中8种活性成分均能与LTA4H进行对接,其抗炎作用机制可能与抑制花生四烯酸5-LOX代谢通路有关。 OBJECTIVE To study the effects of active ingredients in Belamcanda chinensis on the arachidonic acid metabolizing enzymes bymolecular docking technology.METHODS With AUTODOCK software,eight active ingredients in Belamcanda chinensis were selected by using LTA4 H as the ligands.RESULTS The compositions of Belamcanda chinensis bind within LTA4H active site,with binding free energies between-7.85 and -10.29kcal·mol-(-1),and interact with residues of Glu296,Asp375,Arg563 and ser379,etc.CONCLUSION The interactions between active ingredients in Belamcanda chinensis and the leukotriene A4 hydrolase can be successfully carried outmolecular docking.The mechanism of anti-inflammatory action of Belamcanda chinensis is related to the inhibition of the 5-lipoxygenase pathway of arachidonic acid metabolization.
出处 《海峡药学》 2017年第2期33-34,共2页 Strait Pharmaceutical Journal
基金 国家自然基金资助项目(81273927) 辽宁省自然科学基金项目(2015020387)
关键词 射干 分子对接 花生四烯酸 白三烯A4水解酶 计算机辅助药物设计 Belamcanda chinensis Molecular docking Arachidonic acid LTA4H Computer aided drug design
  • 相关文献

参考文献4

二级参考文献75

  • 1叶京英,韩德民.慢性咽炎研究进展[J].中国医学文摘(耳鼻咽喉科学),2004,19(5):268-271. 被引量:49
  • 2王姣,刘学杰,仲英.射干的现代研究概况[J].齐鲁药事,2007,26(3):168-171. 被引量:11
  • 3Miller DK, Gillard JW, Vickers P J, et al. Identification and isolation of a membrane-protein necessary for leukotriene production [J]. Nature, 1990, 343: 278-281.
  • 4Tsuji F, Oki K, Fujisawa K, et al. Involvement of leukotriene B4 in arthritis models [J]. Life Sci, 1998, 64: 151-156.
  • 5Penning TD. Inhibitors of leukotriene A4 (LTA4) hydrolase as potential anti-inflammatory agents [J]. Curr Pharm Des, 2001, 7: 163-179.
  • 6Penning TD, Chandrakumar NS, Desai BN, et al. Synthesis of imidazopyridines and purines as potent inhibitors of leukotriene A4 hydrolase [J]. Bioorg Med Chem Lett, 2003, 13: 1137-1139.
  • 7Grice CA, Tays KL, Savall BM, et al. Identification of a potent, selective, and orally active leukotriene A4 hydrolase inhibitor with anti-inflammatory activity [J]. J Med Chem, 2008, 51: 4150-4169.
  • 8Ye B, Bauman J, Chen M, et al. Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase [J]. Bioorg Med Chem Lett, 2008, 18: 3891-3894.
  • 9Haeggstrom JZ. Leukotriene A4 hydrolase/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis [J]. J Biol Chem, 2004, 279: 50639-50642.
  • 10Thunnissen MM, Andersson B, Samuelsson B, et al. Crystal structures of leukotriene A4 hydrolase in complex with captopril and two competitive tight-binding inhibitors [J]. FASEB J, 2002, 16: 1648-1650.

共引文献56

同被引文献155

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部